Sandoz announced that it began construction on a new, state-of-the-art biosimilars production center in Brnik, Slovenia. The $440 million project enables sterile product manufacturing in the region. It brings the company’s total planned and ongoing investment in Slovenia to more than $1.1 billion by 2029. Sandoz already has ongoing investments there, including a new biosimilar…
Nymi, Caliber partner on passwordless authentication for pharma manufacturing
Nymi today announced a strategic partnership with Caliber Technologies to accelerate digital transformation in pharmaceutical manufacturing. The partnership aims to enable passwordless authentication on the shop floor. This reduces manual logins and streamlines electronic signatures. Nymi offers the Band biometric, wearable device that authenticates users via fingerprint and facilitates a secure, continuous identity across applications,…
Moving toward the autonomous lab and what’s possible today
It comes as no surprise that automation and contextualized data are popular topics of conversation in life sciences today. After all, automation drives repeatability, repeatability drives speed and safety, and increased speed and safety means getting critical treatments into the hands of patients as fast as possible. In fact, one could imagine a result of…
Pharma ingredient manufacturer Antheia raises $56M Series C
Pharmaceutical ingredient manufacturer Antheia announced today that it raised $56 million in Series C financing. The Menlo Park, California-based company aims to deliver ingredients to transform essential medicine supply chains. It plans to use the financing to expand the commercialization of its first product, Thebaine. The company also plans to launch additional products from its…
Roche, Genentech to build $700M drug manufacturing plant in North Carolina
Roche and its Genentech unit today announced plans to invest more than $700 million in a new manufacturing facility in the U.S. The company plans to build a new 700,000 square-foot, state-of-the-art drug manufacturing plant in Holly Springs, North Carolina. It expects to add more than 400 high-wage manufacturing jobs once operational, plus more than…
ICU Medical, Otsuka Pharmaceutical Factory launch joint IV supply chain venture
ICU Medical and Otsuka Pharmaceutical Factory (OPF) announced the formation of a new joint venture to strengthen supply chain resiliency. In this joint venture, the companies say they formed Otsuka ICU Medical LLC. It aims to strengthen IV solutions supply chains and drive innovation in the North American market. The need for a more resilient…
Amgen to spend $900M to expand U.S. biopharma manufacturing
Amgen announced that it plans to invest $900 million to expand its pharmaceutical manufacturing facility in Ohio. The expansion brings the total number of jobs created to 750. Amgen’s total investment in central Ohio now eclipses $1.4 billion. “Amgen has been a leading U.S.-based manufacturer of biologic medicines since 1988. Today’s investment reinforces our ongoing…
Roche to invest $50B in U.S. over next five years
Roche announced plans to invest $50 billion in the U.S. over the next five years to boost manufacturing and R&D. Basel, Switzerland-based Roche says the investments strengthen its U.S. footprint and should create more than 12,000 new jobs. That includes nearly 6,500 construction jobs, plus 1,000 jobs at new and expanded facilities. As part of…
Thermo Fisher to invest $2B on U.S. manufacturing
Thermo Fisher Scientific announced today that it plans to invest an additional $2 billion in the U.S. over the next four years. The company said its investment should strengthen American innovation, manufacturing and economic competitiveness in the life sciences sector. It also comes as a number of companies consider investing in U.S. infrastructure amid potential…
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
Fujifilm Diosynth Biotechnologies, a major contract development and manufacturing organization (CDMO), has entered into a 10-year manufacturing supply agreement with Regeneron Pharmaceuticals, valued at over $3 billion. The deal has the Fujifilm subsidiary providing U.S.-based manufacturing for Regeneron, with planned expansions at Fujifilm’s large-scale biopharmaceutical manufacturing facility in Holly Springs, North Carolina. The Holly Springs…